Zealand Pharma A/S ZLDPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 698.92M | 5.32M | 10.74M | 7.76M | 1.38B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 698.92M | 5.32M | 10.74M | 7.76M | 1.38B |
| Cost of Revenue | -- | -- | 0.00 | -- | -- |
| Gross Profit | 698.92M | 5.32M | 10.74M | 7.76M | 1.38B |
| SG&A Expenses | 18.05M | 16.29M | 14.31M | 29.90M | 16.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 200.00 | -- | 26.62M |
| Total Operating Expenses | 98.36M | 89.74M | 96.93M | 80.03M | 114.08M |
| Operating Income | 600.56M | -84.41M | -86.19M | -72.26M | 1.27B |
| Income Before Tax | 623.44M | -61.70M | -63.36M | -57.45M | 1.23B |
| Income Tax Expenses | 13.85M | -- | -4.27M | 5.87M | 81.68M |
| Earnings from Continuing Operations | 609.59M | -61.70M | -59.09M | -63.32M | 1.15B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 609.59M | -61.70M | -59.09M | -63.32M | 1.15B |
| EBIT | 600.56M | -84.41M | -86.19M | -72.26M | 1.27B |
| EBITDA | 601.96M | -82.85M | -85.80M | -71.13M | 1.27B |
| EPS Basic | 8.67 | -0.87 | -0.84 | -0.90 | 16.29 |
| Normalized Basic EPS | 5.49 | -0.52 | -0.64 | -0.53 | 10.90 |
| EPS Diluted | 8.61 | -0.87 | -0.84 | -0.90 | 16.06 |
| Normalized Diluted EPS | 5.45 | -0.52 | -0.64 | -0.53 | 10.75 |
| Average Basic Shares Outstanding | 70.35M | 70.61M | 70.35M | 70.30M | 70.73M |
| Average Diluted Shares Outstanding | 70.78M | 70.61M | 70.35M | 70.30M | 71.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |